- Home
- EPRX vs WAI Comparison
EPRX vs WAI Comparison
Compare EPRX & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- WAI
- Stock Information
- Founded
- EPRX 2011
- WAI 2018
- Country
- EPRX Canada
- WAI China
- Employees
- EPRX N/A
- WAI N/A
- Industry
- EPRX
- WAI
- Sector
- EPRX
- WAI
- Exchange
- EPRX NYSE
- WAI NYSE
- Market Cap
- EPRX 109.7M
- WAI 87.8M
- IPO Year
- EPRX N/A
- WAI 2023
- Fundamental
- Price
- EPRX $3.20
- WAI $0.33
- Analyst Decision
- EPRX Strong Buy
- WAI
- Analyst Count
- EPRX 1
- WAI 0
- Target Price
- EPRX $9.00
- WAI N/A
- AVG Volume (30 Days)
- EPRX 6.9K
- WAI 82.4K
- Earning Date
- EPRX 02-07-2025
- WAI 02-21-2025
- Dividend Yield
- EPRX N/A
- WAI N/A
- EPS Growth
- EPRX N/A
- WAI N/A
- EPS
- EPRX N/A
- WAI N/A
- Revenue
- EPRX N/A
- WAI $3,989,698.00
- Revenue This Year
- EPRX N/A
- WAI N/A
- Revenue Next Year
- EPRX N/A
- WAI N/A
- P/E Ratio
- EPRX N/A
- WAI N/A
- Revenue Growth
- EPRX N/A
- WAI N/A
- 52 Week Low
- EPRX $2.20
- WAI $0.19
- 52 Week High
- EPRX $4.08
- WAI $1.75
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- WAI N/A
- Support Level
- EPRX N/A
- WAI N/A
- Resistance Level
- EPRX N/A
- WAI N/A
- Average True Range (ATR)
- EPRX 0.00
- WAI 0.00
- MACD
- EPRX 0.00
- WAI 0.00
- Stochastic Oscillator
- EPRX 0.00
- WAI 0.00
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).